Authors:
Mohr, DC
Boudewyn, AC
Likosky, W
Levine, E
Goodkin, DE
Citation: Dc. Mohr et al., Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject, ANN BEHAV M, 23(2), 2001, pp. 125-132
Authors:
Mohr, DC
Goodkin, DE
Masuoka, L
Dick, LP
Russo, D
Eckhardt, J
Boudewyn, AC
Bedell, L
Citation: Dc. Mohr et al., Treatment adherence and patient retention in the first year of a Phase-IIIclinical trial for the treatment of multiple sclerosis, MULT SCLER, 5(3), 1999, pp. 192-197
Citation: Jh. Liem et Ac. Boudewyn, Contextualizing the effects of childhood sexual abuse on adult self- and social functioning: An attachment theory perspective, CHILD ABUSE, 23(11), 1999, pp. 1141-1157
Authors:
Mohr, DC
Likosky, W
Dwyer, P
Van der Wende, J
Boudewyn, AC
Goodkin, DE
Citation: Dc. Mohr et al., Course of depression during the initiation of interferon beta-1a treatmentfor multiple sclerosis, ARCH NEUROL, 56(10), 1999, pp. 1263-1265
Authors:
Mohr, DC
Likosky, W
Boudewyn, AC
Marietta, P
Dwyer, P
Van Der Wende, J
Goodkin, DE
Citation: Dc. Mohr et al., Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a, MULT SCLER, 4(6), 1998, pp. 487-489